Search & Filter

A number of recent trials have revealed Low Intensity Vibration (LIV) to be a safe and effective treatment for bone loss in children.

Pharmacists are being urged to be aware of patients coming to them with potential signs and symptoms of mouth cancer after it emerged that the public are very likely to turn to them, rather than their dentist or doctor, if they have symptoms related to mouth cancer.

Being prescribed non-medical treatments, such as sports groups or cookery courses, by their doctors is benefitting people with mental health conditions, a pilot has found.

More than a quarter (28%) of men said they had not sought medical help for the last mental health problem they experienced compared to 19% of women, a survey has found.

A team of researchers led by the University of Birmingham have found that targeting as few as one in 12 adults for a heart check-up achieves most of the benefits of mass screening at a fraction of the cost.

A new analysis indicates that many men with prostate cancer obtain second opinions from urologists before starting treatment, but surprisingly, second opinions are not associated with changes in treatment choice or improvements in perceived quality of prostate cancer care.

Divergent perceptions and attitudes about obesity may jeopardise obesity management outcomes, according to findings from the Awareness, Care & Treatment In Obesity Management (ACTION) study.

New data on shingles candidate vaccine Shingrix was presented at the Infectious Disease Week (ID Week) scientific conference in New Orleans, USA, this week.

UK charity Heart Valve Voice has launched a report entitled 'Towards a Heart Healthy Future: a 2020 Vision for Heart Valve Disease' at a parliamentary event attended by MPs across the country. 

Men who have worked night shifts for more than 20 years, or who work night shifts without daytime napping, or sleep for more than ten hours per night on average may have an increased risk of cancer, according to a study published in Annals of Medicine.

Noqdirna, the only licenced treatment for the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults including the over 65s has been launched, following approval by the UK Medicines and Healthcare Products Regulatory Agency, Ferring Pharmaceuticals has announced.

Haemoglobin spray Granulox, which is used in the treatment of chronic wounds, has been added to the NHS Drug Tariff, establishing a new Haemoglobin category. The first of its kind, Granulox is now available on prescription across the UK, infirst Healthcare has announced.

New data from the first health-related quality of life (HRQL) study related to post-meal or postprandial glucose (PPG) control, show that poor PPG control has a significant negative impact on quality of life for people with diabetes.

A new treatment called Noqdirna (oral lyophilisate desmopressin) for the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults has been launched following approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA). 

The haemoglobin spray Granulox has been added to the NHS Drug Tariff, establishing a new Haemoglobin category and is used in the treatment of chronic wounds. It will now be available on prescription across the UK.